SCHEMBL10107178

SCHEMBL10107178

COc1ccc([N+](=O)[O-])cc1CNCC(C)C(=O)N(Cc1cc(Cl)c2c(c1)OCCCO2)CC(C)C

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.60
CETP P11597 1/20 0.38
LMNA P02545 4/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 7/20 0.36
CYP3A4 P08684 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HPGD P15428 1/20 0.35
MAPK1 P28482 2/20 0.35
MAPT P10636 4/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
RAB9A P51151 1/20 0.34
THRB P10828 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565204 0.89 PROKR2 (0.63) PROKR2CETPLMNAHTTSMN1; SMN2
SCHEMBL10107176 0.88 PROKR2 (0.63) PROKR2CETPSMN1; SMN2POLBALDH1A1
SCHEMBL564474 0.88 PROKR2 (0.62) PROKR2SMN1; SMN2POLBALDH1A1MAPT
SCHEMBL564977 0.88 PROKR2 (0.63) PROKR2POLBALDH1A1MAPTMEN1
SCHEMBL565781 0.87 PROKR2 (0.69) PROKR2LMNAHTTALDH1A1NPSR1
SCHEMBL564884 0.87 PROKR2 (0.69) PROKR2LMNAHTTALDH1A1NPSR1
SCHEMBL565571 0.87 PROKR2 (0.60) PROKR2POLBALDH1A1MAPTMEN1
SCHEMBL565057 0.86 PROKR2 (0.56) PROKR2SMN1; SMN2ALDH1A1MAPK1MAPT
SCHEMBL564991 0.84 PROKR2 (0.68) PROKR2SMN1; SMN2POLBCYP3A4RAB9A
SCHEMBL564583 0.84 PROKR2 (0.63) PROKR2CETPALDH1A1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885CETP 2919/4885LMNA 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.